Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cv Sciences Inc (OP: CVSI ) 0.0565 +0.0025 (+4.63%) Streaming Delayed Price Updated: 3:58 PM EDT, Jun 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Cv Sciences Inc < Previous 1 2 3 4 5 6 Next > Bearish Monday For Marijuana Stocks - EVIO, Item 9 Labs Among Top Gainers August 07, 2023 Via Benzinga Marijuana Stock Movers For July 17, 2023 July 17, 2023 Via Benzinga CV Sciences FY22 Revenue Declines 19% To $16.2M March 29, 2023 CV Sciences, Inc. (OTCQB: CVSI) FY 2022 revenue was $16.2 million, a 19% decrease compared to $20.0 million for 2021. Q4 2022 Financial Highlights Via Benzinga Why Is CV Sciences Stock Up Today? November 14, 2022 CV Sciences (OTCQB: CVSI) shares were trading 10.69% higher at $0.044 per share at the time of writing Monday morning on company's third-quarter financial results. Via Benzinga Cannabis Stock Gainers And Losers From August 4, 2023 August 04, 2023 Via Benzinga Bullish Thursday For Marijuana Stocks - Choom Holdings, EVIO Among Top Gainers July 13, 2023 Via Benzinga CV Sciences Adds +PlusCBD Relief Softgels To Wellness Line Of CBD Products March 08, 2022 CV Sciences, Inc. (OTCQB:CVSI) added +PlusCBD ... Via Benzinga Nutrition Giant GNC To Distribute CBD Products In 770 Stores In US January 06, 2022 Hemp cannabidiol (CBD) products maker CV Sciences, Inc. (OTCQB: Via Benzinga Marijuana Stock Movers For August 2, 2023 August 02, 2023 Via Benzinga Marijuana Stock Movers For July 12, 2023 July 12, 2023 Via Benzinga Marijuana Stock Movers For July 31, 2023 July 31, 2023 Via Benzinga Cannabis Stock Gainers And Losers From July 11, 2023 July 11, 2023 Via Benzinga Cannabis Stock Gainers And Losers From July 28, 2023 July 28, 2023 Via Benzinga Cannabis Stock Movers For July 10, 2023 July 10, 2023 Via Benzinga Cannabis Stock Gainers And Losers From July 26, 2023 July 26, 2023 Via Benzinga CV Sciences Inc Q1 Revenue Stagnates YoY, Here Is What You Need To Know May 15, 2023 CV Sciences, Inc. (OTCQB: CVSI) released its financial results today for the first quarter ended March 31, 2023, revealing revenues of $4.1 million for the first quarter of 2023 compared to $4.4... Via Benzinga Popular CBD Brand Questions Study: 'Misleading To Consumers And Damaging To The Industry' April 10, 2023 NextEvo Naturals recently released results from a third-party study on 16 CBD products that were allegedly randomly selected for the research. The brand commissioned Coral Reef Labs to conduct this... Via Benzinga Cannabis Stock Movers For July 24, 2023 July 24, 2023 Via Benzinga CBD And Nicotine Formula To Treat Smokeless Tobacco Addiction Receives Patent From Japan, FDA Approval Next March 23, 2023 CV Sciences, Inc. (OTCQB: CVSI) received a formal certificate of grant from the Japan Patent Office for its patent application 7216697. Via Benzinga Biden's Pardon For Cannabis Offenders: 27 Reactions From Politicians, Industry Executives And Advocacy Orgs October 07, 2022 President Joe Biden announced on Thursday that he will pardon all prior federal offenses for simple marijuana possession, sending Via Benzinga Cannabis Stock Movers For July 19, 2023 July 19, 2023 Via Benzinga The CBD Gold Rush Is Over (And That's A Great Thing For Consumers) August 24, 2022 By Bharat Ayyar Disclaimer: I am not a financial advisor. Nothing contained in this post should be construed as investment advice. CV Sciences (OTC: CVSI), the company behind +PlusCBD, had a meteoric... Via Benzinga Marijuana As An Appetite Suppressant? It's A Possibility June 30, 2022 Using cannabis as an appetite suppressant for weight management may seem counterintuitive, but one rare cannabinoid may have just that effect. Delta-9 (d-9)-dominant tetrahydrocannabivarin (THCV) has... Via Benzinga CV Sciences Q1 Revenue Down 8.33%, CEO Encouraged As PlusCBD Brand Gains Market Share May 16, 2022 CV Sciences, Inc. (OTCQB: CVSI) released its financial results for the quarter ended March 31, 2022, revealing a revenue drop of 8.33% to $4.4 million YoY. First Quarter 2022 and Recent Financial and... Via Benzinga A Preview Of CV Sciences's Earnings March 30, 2022 CV Sciences (OTC:CVSI) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that CV Sciences will... Via Benzinga Dry January Got You Down? Cannabis To The Rescue With Tokes, Yummy Gummies And More January 11, 2022 After the hustle and bustle of the holidays, many people are looking to curtail their consumption of alcohol and are therefore partaking in Via Benzinga CV Sciences Launches +PlusCBD Pain Relief Topicals With Products For Athletes, Arthritis Patients January 11, 2022 CV Sciences, Inc. (OTCQB:CVSI) is launching +PlusCB... Via Benzinga Is Medical Marijuana Really A Slippery Slope? CVSI Distribution Agreement with GNC January 05, 2022 The Best Daily Overview Of The Cannabis Space CV Sciences Announces New Distribution Agreement with GNC. $CVSI ... Via Benzinga Trending Up: $TLLTF $VRNOF $UNRV, GOP Cannabis Bill, Cause for Hope? — Cannabis Daily November 16, 2021 November 16, 2021 The Best Daily Overview Of The Cannabis Space Representativ... Via Benzinga Topics Cannabis Exposures Cannabis The Week In Cannabis: Stocks Down, Republican Legalization Bill, Germany, Uruguay, Earnings, New ETF And More November 19, 2021 Below is a recap of the main news related to the cannabis industry and markets for the week of November 15, 2021. Via Benzinga Topics Cannabis Exposures Cannabis < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.